Viewing Study NCT06848920


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-20 @ 6:03 PM
Study NCT ID: NCT06848920
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-27
First Post: 2025-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
Sponsor: Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Differentiated Thyroid Carcinoma (DTC) View
None Neoadjuvant Therapy View
Keywords: